Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : PCLX-001
Therapeutic Area : Oncology
Study Phase : IND Enabling
Sponsor : Canadian Angel Investors
Deal Size : $3.9 million
Deal Type : Financing
Pacylex Raises US $3.9 Million To Advance New Cancer Therapy PCLX-001 Towards Clinical Trials
Details : These funds will support advancing the Company’s first product, PCLX-001, to clinical trials anticipated to start later this year.
Product Name : PCLX-001
Product Type : Other Small Molecule
Upfront Cash : Undisclosed
April 03, 2020
Lead Product(s) : PCLX-001
Therapeutic Area : Oncology
Highest Development Status : IND Enabling
Sponsor : Canadian Angel Investors
Deal Size : $3.9 million
Deal Type : Financing
Reset All
